Radiant is a biotechnology company developing the next generation of multi-specificity.
Radiant Biotherapeutics has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Radiant Biotherapeutics's investors include Bill & Melinda Gates Foundation, BDC Venture Capital, Alexandria Venture Investments, Aberdeen, Amplitude Venture Capital.
Radiant Biotherapeutics is headquartered in Toronto, Canada.
Radiant is a biotechnology company developing the next generation of multi-specificity.
Radiant Biotherapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Radiant Biotherapeutics — Funding & Investors." VCBacked, September 11, 2024, https://www.vcbacked.co/company/radiant-biotherapeutics. Accessed August 13, 2026.
VCBacked. (2024). Radiant Biotherapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/radiant-biotherapeutics
{{cite web |title=Radiant Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/radiant-biotherapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated